Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
- PMID: 28231805
- PMCID: PMC5324300
- DOI: 10.1186/s12985-017-0710-z
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
Abstract
Due to the low fidelity of the RNA-dependent RNA polymerase, Hepatitis C virus (HCV) mutates quite frequently. There are seven genetically divergent genotypes (GTs) distributed in the world, each of which contains several closely related subtypes. The peer-reviewed literatures reporting the prevalence rate of HCV GTs in Chinese hospitalized patients were identified by systematic searching of three electronic databases, and the prevalence rates were pooled through 137 qualified studies. The significant difference between HCV GT and HCV viral load and severity of hepatitis were analyzed under Chi-squared or Fisher's exact test. Data from epidemiological studies on hospitalized patients demonstrated that HCV GTs 1-6 have been found in China, of which 1b (62.78%(95% CI: 59.54-66.02%)) and 2a (17.39% (95% CI: 15.67-19.11%)) are the two predominant subtypes. HCV GTs and subtypes exhibits significant regional divergence. In North, Northwest, Northeast, East (except Jiangxi province) and Central China (except Hunan province), HCV-1b, 2a remain the two predominant subtypes; South China shows the most abundant genetic diversity that 14 subtypes were found, and HCV-3 in the Southwest China remains higher prevalent subtype than the other regions. In addition, co-infection in Liaoning province of Northeast China is the most diverse with 10 co-infection types, and Tibet has the highest rate of co-infection. The associations between HCV GTs and patients group, severity of illness and antiviral treatment efficacy were also discussed in this review.
Keywords: Antiviral treatment efficacy; Co-infection; Distribution; HCV genotype; Population demographics; Subtypes.
Figures


Similar articles
-
Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19. J Med Virol. 2013. PMID: 23868809
-
Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.J Virol. 2014 Jul;88(13):7120-9. doi: 10.1128/JVI.00414-14. Epub 2014 Apr 9. J Virol. 2014. PMID: 24719413 Free PMC article.
-
[Comparison of genotypes of hepatitis C virus between Chinese and Burmese drug users living in Dehong Prefecture, Yunnan Province].Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Nov 6;50(11):959-965. doi: 10.3760/cma.j.issn.0253-9624.2016.11.008. Zhonghua Yu Fang Yi Xue Za Zhi. 2016. PMID: 27903358 Chinese.
-
[The different epidemic and evolution of HCV genotypes].Yi Chuan. 2012 Jun;34(6):666-72. doi: 10.3724/sp.j.1005.2012.00666. Yi Chuan. 2012. PMID: 22698736 Review. Chinese.
-
Genetic history of hepatitis C virus genotype 6 in Taiwan.J Formos Med Assoc. 2024 Sep;123(9):926-933. doi: 10.1016/j.jfma.2023.10.013. Epub 2023 Nov 22. J Formos Med Assoc. 2024. PMID: 37996321 Review.
Cited by
-
Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection.Front Public Health. 2022 Sep 9;10:1009413. doi: 10.3389/fpubh.2022.1009413. eCollection 2022. Front Public Health. 2022. PMID: 36159261 Free PMC article.
-
Comparing direct acting antivirals for hepatitis C using observational data - Why and how?Pharmacol Res Perspect. 2020 Oct;8(5):e00650. doi: 10.1002/prp2.650. Pharmacol Res Perspect. 2020. PMID: 32894643 Free PMC article. Clinical Trial.
-
Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China.Virol J. 2022 Jul 14;19(1):117. doi: 10.1186/s12985-022-01849-4. Virol J. 2022. PMID: 35836270 Free PMC article.
-
HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China.Virol Sin. 2022 Oct;37(5):765-768. doi: 10.1016/j.virs.2022.07.005. Epub 2022 Jul 13. Virol Sin. 2022. PMID: 35842093 Free PMC article.
-
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.Infect Dis Ther. 2023 Nov;12(11):2595-2609. doi: 10.1007/s40121-023-00872-4. Epub 2023 Oct 19. Infect Dis Ther. 2023. PMID: 37856013 Free PMC article.
References
-
- Cai LN, Zhu SW, Zhou C, Wang YB, Jiang NZ, Chen H, Tang XY, Wang JH, Chen X, Hu WJ, et al. Infection status of HBV, HCV and HIV in voluntary blood donors of Chinese Nanjing area during 2010–2013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22:1089–1093. - PubMed
-
- C P, G A, J P, L F, Y H: Estimated Global Prevalence of Hepatitis C Virus Infection. [J] Annual Meeting 2004.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous